Citadel Advisors, run by famed hedge fund manager Kenneth Griffin, has revealed in a Form 13F Filing that it owned 752,449 shares of Forest Laboratories, Inc. (NYSE:FRX) which was acquired by Actavis plc (NYSE:ACT) in July this year.
“This filing lists securities holdings reported only form 13 F filed on May 15, 2014, pursuant to a request for confidential treatment that expired on August 14, 2014,” says the filing, which valued the holding at $69.43 million, or about $92.27 per share.
Citadel’s Holdings of Forest Laboratories in March 2014
A reference to Citadel’s 13F activity as on March 31, 2014 reveals...
Login required to continue reading.
Setup a free account to get access to this article (no credit card required).
View Full ArticleAlready a member? Log in here
